[RANKL inhibition in bone metastases].

Subjects

Subjects :

Animals
Bone Neoplasms genetics
Bone Resorption prevention & control
Bone and Bones metabolism
Denosumab
Disease Models, Animal
Humans
Hypercalcemia drug therapy
Mice
Osteoprotegerin physiology
RANK Ligand immunology
RANK Ligand physiology
Receptor Activator of Nuclear Factor-kappa B physiology
Antibodies, Monoclonal, Humanized pharmacology
Antibodies, Monoclonal, Humanized therapeutic use
Bone Neoplasms drug therapy
Bone Neoplasms secondary
Drug Design
Molecular Targeted Therapy
RANK Ligand antagonists & inhibitors

Details

Language :

Japanese

ISSN :

0015-5691

Volume :

141

Issue :

1

Database :

MEDLINE

Journal :

Nihon yakurigaku zasshi. Folia pharmacologica Japonica

Publication Type :

Academic Journal

Accession number :

23302944

Full Text :

https://doi.org/10.1254/fpj.141.22